HealthStream, Inc.HSTMNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank21
3Y CAGR-12.0%
5Y CAGR-17.2%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-12.0%/yr
Annual compound
5Y CAGR
-17.2%/yr
Recent acceleration
Percentile
P21
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 4.28% |
| 2024 | 7.36% |
| 2023 | 2.85% |
| 2022 | 6.28% |
| 2021 | 28.96% |
| 2020 | 10.98% |
| 2019 | 13.11% |
| 2018 | -7.76% |
| 2017 | -3.45% |
| 2016 | 19.34% |